Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates-Reference-Cited by-同舟云学术

Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates

Published:2010-04 Issue:4 Volume:18 Page:754-765
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Fontanellas Antonio,Hervás-Stubbs Sandra,Mauleón Itsaso,Dubrot Juan,Mancheño Uxua,Collantes María,Sampedro Ana,Unzu Carmen,Alfaro Carlos,Palazón Asis,Smerdou Cristian,Benito Alberto,Prieto Jesús,Peñuelas Iván,Melero Ignacio

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms;Bessis;Gene Ther,2004

2. Current strategies and future directions for eluding adenoviral vector immunity;Bangari;Curr Gene Ther,2006

3. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons;Morral;Proc Natl Acad Sci USA,1999

4. Immune responses to AAV in clinical trials;Mingozzi;Curr Gene Ther,2007

5. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector;Smith;Gene Ther,1996

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy;Molecular Therapy - Methods & Clinical Development;2022-12

2. Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics;Genes;2022-10-25

3. Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease;Molecular Therapy - Methods & Clinical Development;2022-06

4. Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases;Gene Therapy;2022-05-24

5. Imaging of Gene and Cell-Based Therapies: Basis and Clinical Trials;Molecular Imaging;2021